Interim Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 694	$ 1,201
Accounts and notes receivable, net	832	861
Inventories	1,223	1,147
Prepaid expenses and other	78	84
Total current assets	2,827	3,293
Property, plant, and equipment	9,274	8,992
Less: Accumulated depreciation	(5,754)	(5,701)
Property, plant, and equipment, net	3,520	3,291
Operating lease right-of-use assets	307
Goodwill and other intangible assets, net	176	181
Investments in affiliates	184	160
Other assets	442	437
Total assets	7,456	7,362
Current liabilities:
Accounts payable	948	1,137
Short-term and current maturities of long-term debt	149	13
Other accrued liabilities	546	559
Total current liabilities	1,643	1,709
Long-term debt, net	4,007	3,959
Operating lease liabilities	254
Deferred income taxes	208	217
Other liabilities	501	457
Total liabilities	6,613	6,342
Commitments and contingent liabilities
Equity
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 188,811,686 shares issued and 163,492,451 shares outstanding at September 30, 2019; 187,204,567 shares issued and 170,780,474 shares outstanding at December 31, 2018)	2	2
Treasury stock, at cost (25,319,235 shares at September 30, 2019; 16,424,093 shares at December 31, 2018)	(1,072)	(750)
Additional paid-in capital	857	860
Retained earnings	1,606	1,466
Accumulated other comprehensive loss	(556)	(564)
Total Chemours stockholders’ equity	837	1,014
Non-controlling interests	6	6
Total equity	843	1,020
Total liabilities and equity	$ 7,456	$ 7,362